Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yvonne Wengström"'
Publikováno v:
The Breast : official journal of the European Society of Mastology
Breast, Vol 51, Iss, Pp 85-93 (2020)
Breast, Vol 51, Iss, Pp 85-93 (2020)
Objectives Neoadjuvant chemotherapy causes distressing symptoms, which have to be managed by patients at home. Assessing and acting upon relevant patient-reported symptoms regularly with the support of mHealth such as apps, has shown to decrease symp
Publikováno v:
Breast (Edinburgh, Scotland). 22(5)
Background: Previous studies include too few patients over 70 years to be able to assess treatment effects on Health Related Quality Of Life (HRQOL) in the older age group. We aimed to follow HRQOL in postmenopausal women (55-80 years) with breast ca
Publikováno v:
Breast (Edinburgh, Scotland). 21(2)
Complaints of poor nocturnal sleep and daytime dysfunction may be frequent among women receiving chemotherapy for breast cancer. A critical review of the literature was conducted, which aimed at summarising and critically analysing findings regarding
Publikováno v:
Breast (Edinburgh, Scotland). 21(4)
Oncoplastic surgery, including immediate breast reconstruction (IBR), is expanding as a result of public demand. IBR in women with breast carcinoma is resource intense and the reconstruction is often completed concurrently with adjuvant oncological t
Autor:
Yvonne Wengström
Publikováno v:
Breast (Edinburgh, Scotland). 17(3)
Inhibiting estrogen production is a common means of preventing breast cancer recurrence. The aromatase inhibitors (AIs) are becoming the preferred treatment over tamoxifen as adjuvant therapy for postmenopausal women with hormone-sensitive early brea
Publikováno v:
Breast (Edinburgh, Scotland). 16(5)
Little is known about patients' experience of, and knowledge about adjuvant endocrine therapy. A European survey was carried out to explore this knowledge gap. The 547 post-menopausal women with early breast cancer, from 9 European countries, complet